Absence of high‐affinity calreticulin autoantibodies in patients with systemic rheumatic diseases and coeliac disease

References

• Fritzler M. J. Clinical relevance of autoantibodies in systemic rheumatic diseases. Mol Biol Rep 1996; 23: 133–45
   PubMed Web of Science ®Google Scholar
• Miles J., Charles P., Riches P. A review of methods available for the identification of both organ‐specific and non‐organ‐specific autoantibodies. Ann Clin Biochem 1998; 35: 19–47
   PubMed Web of Science ®Google Scholar
• Michalak M., Corbett E. F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999; 344: 281–92
   PubMed Web of Science ®Google Scholar
• Michalak M., Robert Parker J. M., Opas M. Ca2+ signalling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 2002; 32: 269–78
   PubMed Web of Science ®Google Scholar
• Orth T., Dörner T., Meyer Zum Büschenfelde K‐H., Mayet W‐J. Complete congenital heart block is associated with increased autoantibody titers against calreticulin. Eur J Clin Invest 1996; 26: 205–15
   PubMed Web of Science ®Google Scholar
• Boehm J., Orth T., Van Nguyen P., Söling H‐D. Systemic lupus erythematosus is associated with increased auto‐antibody titers against calreticulin and Grp94, but calreticulin is not the Ro/SS‐A antigen. Eur J Clin Invest 1994; 24: 248–57
   PubMed Web of Science ®Google Scholar
• Rokeach L. A., Haselby J. A., Meilof J. F., Smeenk R. J. T., Unnasch T. R., Greene B. M. Characterization of the autoantigen calreticulin. J Immunol 1991; 147: 3031–9
   PubMed Web of Science ®Google Scholar
• Houen G., Koch C. Human placental calreticulin: purification, characterization and association with other proteins. Acta Chem Scand 1994; 48: 905–11
   PubMedGoogle Scholar
• Eggleton P., Ward F. J., Johnson S., Khamashta M. A., Hughes G. R., Hajela V. A. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization. Clin Exp Immunol 2000; 120: 384–91
   PubMed Web of Science ®Google Scholar
• van den Berg R. H., Siegert C. E., Faber‐Krol M. C., Huizinga T. W., van Es L. A., Daha M. R. Anti‐C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1998; 111: 359–64
   PubMed Web of Science ®Google Scholar
• Scofield R. H., Racila D. M., Gordon T. P., Kurien B. T., Sontheimer R. D. Anti‐calreticulin segregates anti‐Ro sera in systemic lupus erythematosus: anti‐calreticulin is present in sera with anti‐Ro alone but not in anti‐Ro sera with anti‐La or anti‐ribonucleoprotein. J Rheumatol 2000; 27: 128–34
   PubMed Web of Science ®Google Scholar
• Karská K., Tucková L., Steiner L., Tlaskalová‐Hogenová H., Michalak M. Calreticulin: the potential autoantigen in celiac disease. Biochem Biophys Res Commun 1995; 209: 597–605
   PubMed Web of Science ®Google Scholar
• Tucková L., Karská K., Walters J. R. F., Michalak M., Rossmann P., Krupicková S. Anti‐gliadin antibodies in patients with celiac disease cross‐react with enterocytes and human calreticulin. Clin Immunol Immunopathol 1997; 85: 289–96
   PubMedGoogle Scholar
• Sanchez D., Tucková L., Sebo P., Michalak M., Whelan A., Sterzl I. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases. J Autoimmun 2000; 15: 441–9
   PubMed Web of Science ®Google Scholar
• Kreisel W., Siegel A., Bahler A., Spamer C., Schiltz E., Kist M. High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut‐derived bacterial antigens in its aetiology?. Scand J Gastroenterol 1999; 34: 623–8
   PubMed Web of Science ®Google Scholar
• Manthorpe R., Oxholm P., Prause J. U., Schiodt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986, Suppl 61: 19–21
   Google Scholar
• LeRoy E. C., Black C., Fleishmajer R., Jablonska S., Krieg T., Medsger Jr. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper Healey L. A. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
   PubMed Web of Science ®Google Scholar
• Studier F. W. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol 1973; 79: 237–48
   PubMed Web of Science ®Google Scholar
• Sværke C., Houen G. Chaperone properties of calreticulin. Acta Chem Scand 1998; 52: 942–9
   PubMedGoogle Scholar
• Hansen D., Bennedbæk F. N., Hansen L. K., Høier‐Madsen M., Jacobsen B. B., Hegedüs L. Thyroid function, morphology and autoimmunity in young patients with insulin‐dependent diabetes mellitus. Eur J Endocrinol 1999; 140: 512–8
   PubMed Web of Science ®Google Scholar
• Husby S., Holmskov‐Nielsen U., Jensenius J. C., Erb K. Increased non‐specific binding of heat‐treated proteins to plastic surfaces analyzed by ELISA and HPLC fractionation. J Immunoassay 1985; 6: 95–110
   PubMed Web of Science ®Google Scholar
• Kenna J. G., Major G. N., Williams R. S. Methods for reducing non‐specific antibody binding in enzyme‐linked immunosorbent assays. J Immunol Methods 1985; 85: 409–19
   PubMed Web of Science ®Google Scholar
• Papoian R. Non‐specific immunoglobulin interactions may lead to false‐positive results in assays for human anti‐mouse monoclonal antibodies (HAMA). J Immunoassay 1992; 13: 289–96
   PubMedGoogle Scholar
• Rebeski D. E., Winger E. M., Shin Y‐K., Lelenta M., Robinson M. M., Varecka R. Identification of unacceptable background caused by non‐specific protein adsorption to the plastic surface of 96‐well immunoassay plates using a standardized enzyme‐linked immunosorbent assay procedure. J Immunol Meth 1999; 226: 85–92
   PubMed Web of Science ®Google Scholar
• Boscato L. M., Stuart M. C. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988; 34: 27–33
   PubMed Web of Science ®Google Scholar
• Ward G., McKinnon L., Badrick T., Hickman P. E. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol 1997; 108: 417–21
   PubMed Web of Science ®Google Scholar
• Dawkins R. L., Pummer S. C., Krueger R. G., Hollingsworth P. N. Heterophile antibodies. Autoantibodies, J. B Peter, Y Shoenfeld. Elsevier Science, Amsterdam 1996; 351–6
   Google Scholar
• Tønder O., Natvig J. B., Matre R. Antibodies in human sera to rabbit erythrocytes. Immunol 1967; 12: 629–37
   PubMed Web of Science ®Google Scholar
• Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 1940; 18: 172–88
   Google Scholar
• Ogden C. A., deCathelineau A., Hoffmann P. R., Bratton D., Ghebrehiwet B., Fadok V. A. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194: 781–95
   PubMed Web of Science ®Google Scholar
• Vandivier R. W., Ogden C. A., Fadok V. A., Hoffmann P. R., Brown K. K., Botto M. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169: 3978–86
   PubMed Web of Science ®Google Scholar
• Uwatoko S., Aotsuka S., Okawa M., Egusa Y., Yokohari R., Aizawa C. C1q solid‐phase radioimunoassay:binding properties of solid‐phase C1q and evidence that C1q‐binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q. J Immunol Meth 1984; 73: 67–74
   PubMed Web of Science ®Google Scholar
• Uwatoko S., Aotsuka S., Okawa M., Egusa Y., Yokohari R., Aizawa C. C1q solid‐phase radioimmunoassay: evidence for detection of antibody directed against the collagen‐like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 69: 98–106
   PubMed Web of Science ®Google Scholar
• Steinø A., Jørgensen C. S., Laursen I., Houen G. Interaction of C1q with the receptor calreticulin requires a conformational change in C1q. Scand J Immunol 2004; 59: 458–95
   PubMed Web of Science ®Google Scholar
• Staikov E. V., Routsias J. G., Makri A. A., Terzoglou A. A., Sakarellos‐Daitsiotis M., Sakarellos C. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti‐Ro60 kD autoantibodies. Clin Exp Immunol 2003; 134: 143–50
   PubMed Web of Science ®Google Scholar